Forma Medical Announces Strategic Focus on OptimalMTP™, Issuance of Key Methods Patent, and Appointment of Aaron Smith to Board of Directors

2026-01-29 - 13:40

CAMP HILL, Pa. -- Forma Medical Inc. announced a sharpened strategic focus on OptimalMTPTM, a procedural innovation enabling minimally invasive plating of first metatarsophalangeal (MTP) joint fusion, along with the issuance of a key methods patent and the appointment of Aaron Smith, former CEO of Artelon, to its Board of Directors. Read More